[Treatment of chronic bronchopulmonary diseases with a N-(2-amino-3,5-dibromobenzyl-N-methyl-N-cyclohexl-ammonium chloride and benzidamine chlorohydrate combination].
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000188:drug therapy*; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006851:Hydrochloric Acid; D008171:Lung Diseases / Q000188:drug therapy*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D005100:Expectorants; D011720:Pyrazoles; D000644:Quaternary Ammonium Compounds; D006851:Hydrochloric Acid
Tratamiento de enfermedades broncopulmonares crónicas con una asociación de N (2-amino3,5 dibromobencil)-N-metil-N-ciclohexil-amonio, clouro y clorhidrato de benzidamina.